1. "Bone Marrow Transplant"
Formats
  1. Meeting Abstract (1488)
  2. Journal Article (1179)
  3. Review (70)
  4. Research Letter (46)
  5. Book Section (34)
  6. Guidelines (26)
  7. Editorial (23)
  8. Correspondence (17)
  9. Conference Paper (14)
  10. Book Whole (1)
  11. Miscellaneous (1)
Groups
  1. Bone Marrow Transplant (2899)
  2. Center for Hematologic Malignancies (2899)
  3. Department of Medicine (2899)
  4. Hematologic Malignancies, Division of (2776)
  5. Survivorship Research (1345)
  6. GSK Faculty (917)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Sean Devlin (457)
  4. Ann Jakubowski (456)
  5. Heather Landau (419)
  6. Gunjan Shah (418)

More People

Years
  1. 2025 (40)
  2. 2024 (169)
  3. 2023 (263)
  4. 2022 (201)
  5. 2021 (177)
  6. 2020 (208)

More Years

Publications
  1. Blood (840)
  2. Biology of Blood and Marrow Transplantation (516)
  3. Bone Marrow Transplantation (175)
  4. Journal of Clinical Oncology (125)
  5. Transplantation and Cellular Therapy (110)
  6. Blood Advances (88)

More Publications

Publishers
  1. American Society of Hematology (935)
  2. Elsevier Inc. (762)
  3. Nature Publishing Group (258)
  4. American Society of Clinical Oncology (127)
  5. Wiley Blackwell (65)
  6. Taylor & Francis Group (64)

More Publishers

Results (2899)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Human natural killer cells achieve tolerance by preferentially endowing functional competence to inhibitory killer Ig-like receptors specific for self-HLA class I
    Meeting Abstract

    Yu, J.; Pinto-Agnello, C.; Chewning, J.; Hsu, K. C.
    Blood (2006)

    Fulltext@MSK | Save
  • Pilot trial of rituximab for the prevention of Epstein Barr virus B cell lymphoproliferative disorder (EBV-LPD) following T cell depleted (TCD) unrela ted or HLA-mismatched related hematopoietic stem cell transplantation
    Meeting Abstract

    Small, T. N.; Kernan, N. A.; Jakubowski, A.; Young, J. W.; Prockop, S.; Perales, M. A.; O'Reilly, R. J.; Papadopoulos, E. B.
    Blood (2006)

    Fulltext@MSK | Save
  • Treatment outcome after induction chemotherapy before allogeneic hematopoietic SCT in patients with advanced MDS
    Meeting Abstract

    Ramos, C. A.; Jakubowski, A. A.; Boulad, F.; Papadopoulos, E. B.; Young, J. W.; Kernan, N. A.; Perales, M. A.; Small, T. N.; Berman, E.; O'Reilly, R. J.; more...
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Immunogenicity of haemophilus influenza and pneumococcal vaccines in related and unrelated transplant recipients
    Meeting Abstract

    Pao, M. K.; Papadopoulos, E. B.; Kernan, N. A.; Jakubowski, A. A.; Young, J. W.; Castro-Malaspina, H. R.; Perales, M. A.; O'Reilly, R. J.; Boulad, F.; Prockop, S.; more...
    Blood (2006)

    Fulltext@MSK | Save
  • High leveI T cell suppression following purine analog therapy for patients with CLL correlates with important clinical benefit
    Meeting Abstract

    Landau, H.; Lamanna, N.; Hobart, S.; Weiss, M. A.
    Blood (2006)

    Fulltext@MSK | Save
  • AL amyloidosis in a patient with a T60A TTR mutation
    Meeting Abstract

    Landau, H.; Comenzo, R. L.; Zhou, P.; Clark, B.; Teruya-Feldstein, J.; Wang, S.; Murphy, C. L.; Solomon, A.
    Amyloid (2006)

    Fulltext@MSK | Save
  • Results of T cell depleted (TCD) allogeneic hematopoietic stem cell transplantation (AlloHSCT) from HLA matched (HLA-M) or partially mismatched (HLA-MM) unrelated donors (URD) in patients with hematologic malignancies: Sustained engraftment and low incidence of graft-vs-host disease (GvHD)
    Meeting Abstract

    Jakubowski, A. A.; Papadopoulos, E. B.; Kernan, N. A.; Boulad, F.; Castro-Malaspina, H. R.; Collins, N. H.; Hsu, K.; Perales, M. A.; Small, T. N.; Van Den Brink, M.; more...
    Blood (2006)

    Fulltext@MSK | Save
  • Lack of predictive value of KIR-HLA genotypes for autologous transplant outcome for multiple myeloma
    Meeting Abstract

    Hsu, K. C.; Tricot, G.; Haessler, J.; Pinto-Agnello, C.; Van Rhee, F.; Fox, M.; Dupont, B.
    Blood (2006)

    Fulltext@MSK | Save
  • Induction of remission prior to transplantation improves the disease-free survival (DFS) of patients with advanced myelodysplastic syndromes (MDS) treated with myeloablative T - Cell depleted (TCD) stem cell transplants (SCT) from histocompatible unrelated donors
    Meeting Abstract

    Castro-Malaspina, H. R.; Jakubowski, A. A.; Papadopoulos, E. B.; Boulad, F.; Young, J. W.; Kernan, N. A.; Perales, M. A.; Small, T. N.; Chiu, M.; Heller, G.; more...
    Blood (2006)

    Fulltext@MSK | Save
  • CD32B on clonal plasma cells in systemic light-chain amyloidosis (AL) and multiple myeloma (MM): A target for immunotherapy in both disorders and a prognostic marker in MM
    Meeting Abstract

    Boruchov, A.; Zhou, P.; Olshen, A.; Rankin, C.; Bonvini, E.; Koenig, S.; Fleisher, M.; Rose, R.; McKenzie, S.; Maslak, P.; more...
    Blood (2006)

    Fulltext@MSK | Save